Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome
Ryan Allway May 12th, 2022 Psychedelics, Top News — Review of Phase I ready BMB-101 and upcoming milestones — — Webcast to be held on May 19, 2022, 4:00pm ET — VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”)... Read more
Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial
Ryan Allway March 14th, 2022 Psychedelics, Top News VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today... Read more
Judge: California child can take cannabis drug to school
SANTA ROSA (AP) — A California kindergartner can keep bringing a cannabis-based drug used for emergency treatment of a rare form of epilepsy to her public school, a judge ruled Friday. The Santa Rosa Press-Democrat reported that a judge sided with the family of 5-year-old Brooke Adams. In this... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )